Radiofrequency-triggered release for on-demand delivery of therapeutics from titania nanotube drug-eluting implants

Nanomedicine (Lond). 2014;9(8):1263-75. doi: 10.2217/nnm.13.93. Epub 2013 Dec 20.

Abstract

Aim: This study aimed to demonstrate radiofrequency (RF)-triggered release of drugs and drug carriers from drug-eluting implants using gold nanoparticles as energy transducers.

Materials & methods: Titanium wire with a titania nanotube layer was used as an implant loaded with indomethacin and micelles (tocopheryl PEG succinate) as a drug and drug carrier model. RF signals were generated from a customized RF generator to trigger in vitro release.

Results & discussion: Within 2.5 h, 18 mg (92%) of loaded drug and 14 mg (68%) of loaded drug carriers were released using short RF exposure (5 min), compared with 5 mg (31%) of drug and 2 mg (11%) of drug carriers without a RF trigger. Gold nanoparticles can effectively function as RF energy transducers inside titania nanotubes for rapid release of therapeutics at arbitrary times.

Conclusion: The results of this study show that RF is a promising strategy for triggered release from implantable drug delivery systems where on-demand delivery of therapeutics is required.

Keywords: drug-eluting implant; gold nanoparticle; micelle; noninvasive drug delivery; polymer; radiofrequency; titania nanotube; triggered drug release; water-insoluble drug.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Drug Implants / chemistry*
  • Equipment Design
  • Gold / chemistry
  • Indomethacin / administration & dosage*
  • Metal Nanoparticles / chemistry
  • Micelles
  • Nanotubes / chemistry*
  • Nanotubes / ultrastructure
  • Radio Waves
  • Titanium / chemistry*
  • Transducers

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Drug Implants
  • Micelles
  • titanium dioxide
  • Gold
  • Titanium
  • Indomethacin